Cover Image
市場調查報告書

全球膽固醇檢驗市場

Cholesterol Testing

出版商 Global Industry Analysts, Inc. 商品編碼 236841
出版日期 內容資訊 英文 239 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球膽固醇檢驗市場 Cholesterol Testing
出版日期: 2017年09月01日 內容資訊: 英文 239 Pages
簡介

本報告提供全球膽固醇檢驗市場相關調查,彙整市場趨勢與2016∼2024年的預測,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 膽固醇檢驗:概要
    • 全球醫療領域的趨勢促進市場成長
    • 醫療費急劇上升
    • 醫療·診斷服務的可利用性擴大
    • 已開發國家是主要的收益貢獻國
    • 發展中國家提供莫大可能性
    • 競爭模式
    • 膽固醇篩檢服務:市場結構
    • 實驗設備市場:主要企業
    • M&A活動
  • 值得一提的市場趨勢,促進要素,課題
  • 廣泛的預測
    • 血中膽固醇
    • 膽固醇的種類
    • 風險因素和風險層級
    • 膽固醇檢驗的必要性
    • 膽固醇檢驗的種類 其他
  • 產品/服務引進
  • 近幾年的產業活動
  • 全球主要企業
    • Abbott Laboratories
    • AccuTech, LLC
    • Akers Biosciences, Inc.
    • Alere Inc.
    • Beckman Coulter, Inc.
    • Bio-Rad Laboratories, Inc.
    • Eurofins Scientific
    • Boston Heart Diagnostics Corporation
    • Home Access Health Corporation
    • Laboratory Corporation of America® Holdings
    • PRIMA Lab SA )
    • PTS Diagnostics
    • Quest Diagnostics, Inc.
    • Randox Laboratories Ltd
    • Roche Diagnostics
    • Sekisui Diagnostics,
    • Siemens Healthineers
    • Sigma-Aldrich Corp.
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-3403

This report analyzes the worldwide markets for Cholesterol Testing in US$ Thousand. The report provides separate comprehensive analytics for Cholesterol Screening and Lab Testing Services for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 29 companies including many key and niche players such as -

Abbott Diagnostics, Inc.
AccuTech, LLC
Akers Biosciences, Inc.
Alere Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Cholesterol Testing - An Overview
  • Prevailing Scenario in the Global Healthcare Sector Favors Market Growth
  • Increasing Healthcare Expenditure
    • Table 1: Healthcare Spending as a Percentage (%) of National GDP for Select Developed Nations (2014) (includes corresponding Graph/Chart)
    • Table 2: Healthcare Spending as a Percentage (%) of National GDP for Select Developing Nations (2014) (includes corresponding Graph/Chart)
    • Table 3: Per-Capita Healthcare Expenditure in US$ for Select Countries/Regions (2014) (includes corresponding Graph/Chart)
  • Wider Availability of Healthcare & Diagnostics Services
  • Growing Health-Consciousness
  • Lenience Towards Preventive Care
  • Developed Regions Remain Key Revenue Contributors
  • Developing Economies Offer Significant Potential
  • Key Factors Driving Demand for Healthcare Services in Developing Regions
    • Growing Healthcare Awareness
    • Increased Access to Healthcare
    • Proliferation of Medical Tourism
  • Competitive Scenario
  • Cholesterol Screening Services - Market Structure
  • Cholesterol Test Equipment Market - Leading Players
    • Vendors Prioritize Collaborations
  • M&A Activity
    • Select M&A Deals in the Global Cholesterol Diagnostics Market (2014-2017)

2. NOTEWORTHY MARKET TRENDS, DRIVERS & CHALLENGES

  • Growing Prevalence of Cardiovascular Disease Steers Demand for Cholesterol Testing
  • Global Menace of Cardiovascular Disease: Quick Facts
  • A Brief Overview of Select Cholesterol-Driven Cardiac Disorders
    • Coronary Artery Disease
    • Hyperlipidaemia
  • CVD Statistics
    • Table 4: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
    • Table 5: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)
    • Table 6: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 7: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 8: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart)
  • Risk of CVD in Obese People Underpins Cholesterol Testing Volumes
  • Global Obesity Facts in a Nutshell
    • Table 9: Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart)
    • Table 10: Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart)
  • Cholesterol Screening Assumes Importance in Diabetes Care
    • Table 11: World Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 12: Global Prevalence of Diabetes - Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2015 & 2040 (includes corresponding Graph/Chart)
    • Table 13: Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender (2015) (includes corresponding Graph/Chart)
    • Table 14: Number of Adults with Diagnosed Diabetes in Urban and Rural Areas (2015 & 2040) (In Million) (includes corresponding Graph/Chart)
    • Table 15: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart)
  • The Hypertension-Cholesterol Link Accelerates the Need for Cholesterol Screening
    • Table 16: Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years (includes corresponding Graph/Chart)
    • Table 17: Economic Burden of Cardiovascular Diseases between 2011 and 2025: Breakdown of Lost Output Value by Income Group (includes corresponding Graph/Chart)
    • Table 18: Percentage of Hypertension-Associated Deaths in Various Non-Communicable Diseases (NCD) (includes corresponding Graph/Chart)
  • Aging Population - A Vital Demography
    • Table 19: Global Population Statistics for 65+ Age Group (Male & Female) for Major Countries/Regions (mid-2016) (includes corresponding Graph/Chart)
    • Table 20: Global Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
  • Uptrend in In-Vitro Diagnostics (IVD) Sector Signals Prospects
    • Table 21: Global In Vitro Diagnostics Market by Test Category (2017E): Percentage Breakdown of Value Sales for Anatomic Pathology, Blood Screen Immunoassay, Coagulation, Hematology, Immunoassay, Microbiology, Molecular Diagnostics, Point-of-Care Diagnostics, and Others (includes corresponding Graph/Chart)
    • Table 22: Global In Vitro Diagnostics Market by Sector (2017E): Percentage Breakdown of Revenues for Decentralized & Patient Self-Testing, and Hospital & Commercial Laboratories (includes corresponding Graph/Chart)
    • Table 23: Global In Vitro Diagnostics Market by Geographic Region (2017E): Percentage Breakdown of Value Sales for the Asia-Pacific, Europe, Latin America, United States, and Rest of World (includes corresponding Graph/Chart)
  • Healthy Growth in Cardiac IVD Market Augments Market Potential
  • Positive Momentum in Point of Care (POC) Diagnostics Generates Parallel Opportunities
  • POC Diagnostics - An Overview
    • Table 24: Global Point Of Care (POC) Diagnostics Market by Category (2017E): Percentage Breakdown of Revenues for Blood Gas Testing, Cardiac Markers, Cholesterol Screening, Coagulation Monitoring, Fertility/Pregnancy Testing, Glucose Monitoring, Hematology Testing, Infectious Diseases Testing and Others (includes corresponding Graph/Chart)
    • Table 25: Global Point Of Care (POC) Diagnostics Market by End-Use Segment (2017E): Percentage Breakdown of Revenues for Clinics, Diagnostic Labs, Hospitals, Self Testing & Others (includes corresponding Graph/Chart)
  • POC Cholesterol Testing Makes Rapid Gains
  • Massive Demand for Lipid Panel/Lipid Profile Tests
  • Northbound Trajectory in POC LPT Services
  • Rise of C-reactive Protein Tests to Aid Market Growth
  • Cholesterol Testing: Evolution from Invasive to Non-Invasive
  • Recent Breakthroughs in Non-Invasive Cholesterol Testing Domain
    • Smartphone-based smartCARD Rapid Diagnostic System
    • Paper-Thin Miniature Sensors
    • PreVu(r) POC Test with Skin Markers
    • Digital Photographs of Patient's Hand to Screen Cholesterol
  • Nonfasting Lipid Testing Invalidates the Need for Pre-Test Fasting
  • Cloud Screening Platforms Extend New Level of Convenience
  • Self-Testing Kits: An Emerging Issue for Full-Scale Services Providers
  • A Rapidly Evolving Market Enabled by Technology
  • Opportunities & Challenges in Self-Testing Industry
  • E-Retailing Drives Sales of Home Test Kits
    • Factors Influencing Online Purchase Decision - Ranked in Order of Influence
  • A Brief Overview of Select Cholesterol Test Kits
    • Roche Diagnostics Accutrend(r) Plus system
    • PTS CardioChek Analyzer Starter Kit
    • PTS CardioChek Deluxe Cholesterol Kit
    • PTS CardioChek Refill Cholesterol Kit
    • AccuTech CholesTrak Home Cholesterol Test Kit 2 ea
    • AccuTech Cholestrak Total Cholesterol Home Testing Kit
    • PRIMA Cholesterol & Triglycerides 2-in-1 Home Test/Meter Kit Monitoring System
    • PRIMA Home Test 3-in-1 Cholesterol, Triglycerides & Glucose Complete Self Testing Kit
    • EasyLife Cholesterol Test Strips
    • Easylife Hemoglobin Cholesterol Glucose Test Meter Kit
    • Solana Health Best Home Complete HDL, Lipid Panel LDL & Triglycerides Test Kit
    • LifeSign DietMate Handheld Weight, Cholesterol, and Hypertension Control Computer

3. CHOLESTEROL TESTING : A BROADER PERSPECTIVE

  • Blood Cholesterol - The Principal Cardiac Risk Marker
  • Types of Cholesterol
  • Total Cholesterol (TC)
  • High Density Lipoprotein (HDL)
  • Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein (VLDL)
  • Triglycerides (TRG)
  • Glucose (GLU)
  • Alanine Aminotransferase (ALT)
  • Outcomes of High Blood Cholesterol
  • Atherosclerosis
  • Coronary Heart Disease (CHD)
  • Risk Factors and Risk Levels
  • Risk Factors
  • Risk Levels
  • Risk Level Classification under National Heart, Lung and Blood Institute's National Cholesterol Education Program (NCEP)
  • Risk Level Based on Total Cholesterol Concentration
    • LDL-Cholesterol Risk Levels
    • HDL-Cholesterol Risk Levels
    • Triglyceride Risk Levels
  • Cholesterol Testing & CVD Risk Assessment Techniques
  • Need for Cholesterol Testing
  • Candidates for Cholesterol Testing
  • Test Procedure
  • Time of Testing - Crucial for Heart Disease Patients
  • Types of Cholesterol Testing
    • Lipid Panel Test/Lipid Profile
      • Total Cholesterol Test
      • HDL Cholesterol Test
      • LDL Cholesterol Testing
      • LDL Cholesterol Test - The First Cholesterol Testing Method
      • Triglycerides/VLDL Cholesterol Testing
    • Apolipoprotein B Test
    • Apolipoprotein A-1 Test
    • ApoE Genotyping Test
    • Apolipoprotein CII
    • Other Key Markers for Cholesterol Testing
      • RLP Cholesterol
      • Non Instrumented Technologies
    • Heart Disease Diagnosis Tests
      • Non-Invasive Tests
      • Invasive Tests
      • Other CVD Markers
      • Creatin Kinase MB
      • Troponin T and Troponin I
      • Myoglobin
      • P-selectin Profile
      • C-reactive Protein
      • Endothelial Dysfunction
      • Homocysteine
      • Plasminogen Activator Inhibitor-1
      • s-100 Protein
      • Thrombus Precursor Protein
      • Other Cardiac Markers
  • Cholesterol Screening & Lab Testing Services Providers
  • Cholesterol Control & Treatment Modalities
  • Dietary Therapy
    • Healthy Diet
    • Exercises
  • Drug Therapy
    • Classification of Cholesterol Lowering Drugs
      • Bile Acid Sequestrants
      • Nicotinic Acid
      • HMG CoA Reductase Inhibitors (Statins)
      • Other Drugs (Fibric Acids and Probucol)
      • Testing After Commencing Drug Therapy

4. PRODUCT/SERVICE INTRODUCTIONS

  • Quest Diagnostics Rolls Out Non-Fasting Cholesterol Tests
  • VAP Diagnostics Lab Relaunches VAP+ Lipid Panel
  • Bio-Rad Laboratories Unveils Bio-Plex Pro(tm) Human Apolipoprotein Panel
  • Color Genomics Launches New Test for Hereditary High Cholesterol
  • Admera Health Unveils New DNA Tests
  • Mayo Clinic Launches Blood Test to Predict Adverse Cardiovascular Events Using Plasma Ceramides
  • PTS Diagnostics Rolls Out PTS Connect(tm) Wellness Solution

5. RECENT INDUSTRY ACTIVITY

  • Abbott Laboratories to Acquire Alere
  • Siemens Healthineers to Expand Massachusetts Facility
  • PTS Bags USFDA Clearance for New Measurement Range for PTS Panels(r)
  • Alere to Divest Triage Assets to Quidel
  • Akers Biosciences Inks Distribution Agreement with First Check Diagnostics
  • Merck to Split into Three Separate Businesses
  • Atonomics Receives CE Marking for Trace Lipids Test Panel
  • Siemens Healthineers Partners with DiA Holding
  • PTS Diagnostics Inks Distribution Agreement with Anda
  • PTS Diagnostics Renews Multi-Year Agreement with Life Line Screening
  • Siemens Healthcare Rebrands itself as Siemens Healthineers
  • Sinocare Acquires PTS Diagnostics
  • Eurofins Snaps Up Boston Heart Diagnostics
  • Merck Acquires Sigma-Aldrich
  • Optum Snaps Up Alere Health from Alere
  • PTS Diagnostics Collaborates with Blinded Diagnostics

6. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Laboratories (USA)
  • AccuTech, LLC (USA)
  • Akers Biosciences, Inc. (USA)
  • Alere Inc. (USA)
  • Beckman Coulter, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Eurofins Scientific (Luxembourg)
  • Boston Heart Diagnostics Corporation (USA)
  • Home Access Health Corporation (USA)
  • Laboratory Corporation of America(r) Holdings (USA)
  • PRIMA Lab SA (Switzerland)
  • PTS Diagnostics (USA)
  • Quest Diagnostics, Inc. (USA)
  • Randox Laboratories Ltd. (UK)
  • Roche Diagnostics (USA)
  • Sekisui Diagnostics, LLC (USA)
  • Siemens Healthineers (Germany)
  • Sigma-Aldrich Corp. (USA)

7. GLOBAL MARKET PERSPECTIVE

    • Table 26: World Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 27: World Historic Review for Cholesterol Screening and Lab Testing Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 28: World 14-Year Perspective for Cholesterol Screening and Lab Testing Services by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • The United States: Largest Market for Cholesterol Screening Services
    • Surge in CVD Incidence - Key Growth Driver
      • CVD Incidence: Key Statistics
    • Table 29: CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart)
    • Table 30: CVD in the US: Cardiovascular Disease Incidence by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart)
    • Table 31: Leading Causes of CVD Fatalities in the US: Percentage Breakdown of Mortality for Coronary Heart Disease, HBP, Heart Failure, Stroke, and Others (includes corresponding Graph/Chart)
    • The Risk of CVD in Chronic Conditions Propels Testing Market
      • Obesity
    • Table 32: Obesity Prevalence in US Adults by Type of Obesity (2015) (includes corresponding Graph/Chart)
    • Table 33: Obesity Prevalence in the US by Age Group (2015) (includes corresponding Graph/Chart)
    • Table 34: Obesity Prevalence in the US by Percentage Annual Income Level of Adult Population (2015) (includes corresponding Graph/Chart)
      • Diabetes
    • Table 35: Diabetes Statistics in North America & Caribbean (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 36: Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 37: Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart)
    • Table 38: Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart)
      • Hypertension
    • Table 39: High Blood Pressure Prevalence in the US by Gender (2016E) (includes corresponding Graph/Chart)
    • Table 40: High Blood Pressure Prevalence in the US (2016E): Prevalence Rates for Male and Female Population by Age Groups (includes corresponding Graph/Chart)
    • Table 41: High Blood Pressure Prevalence in the US (2016E): Prevalence Rates for Male and Female Population by Ethnic Group (includes corresponding Graph/Chart)
    • Ageing Population - Vital Demography
    • Table 42: North American Elderly Population by Age Group: 1975-2050
    • Preventive Care Trend to Widen Growth
    • Uptrend in Point of Care (POC) Diagnostics Enhances Market Prospects
      • Cholesterol POC Testing Market: An Overview
    • Growing Popularity of Consumer Self Testing
      • Expanding Role of HCPs Strengthens Self-Testing Market
      • Prospects & Challenges for Self-Testing Healthcare Devices Market
      • Regulatory Changes Support Self-Testing
      • Increased Preference for Home Test Devices
      • Cholesterol Test Kits Offered by Select Companies
    • Product/Service Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 43: US Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 44: US Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Growing Incidence of CVD & Lifestyle Diseases Augments Test Volumes
    • Table 45: Adult Diabetes in Canada (2015): Percentage Share Breakdown of Diabetic Population by Gender (includes corresponding Graph/Chart)
    • Table 46: Adult Diabetes in Canada (2015): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 47: Canadian Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 48: Canadian Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Aging Population: Key Market Driver
    • Table 49: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 50: Japanese Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 51: Japanese Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Europe: The Second Major Market for Cholesterol Testing
    • CVD Prevalence Steers Testing Volumes
      • Screening Children for Familial Hypercholesterolemia
    • Higher Incidence of Obesity
    • Table 52: Obesity Prevalence as a Percentage (%) of National Population in Select European Countries (2016) (includes corresponding Graph/Chart)
    • Ageing Demography - An Opportunity Indicator
    • Table 53: Population Breakup by Age Group for Select European Countries: 2015 (as Percentage of Total Population) (includes corresponding Graph/Chart)
    • EU-wide Campaigns to Prop Up Market Prospects
  • B. Market Analytics
    • Table 54: European Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 55: European Historic Review for Cholesterol Screening and Lab Testing Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 56: European 14-Year Perspective for Cholesterol Screening and Lab Testing Services by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 57: French Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 58: French Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • German Healthcare System: A Review
    • Table 59: Growth of Senior Citizen Population in Germany: 2000-2025 (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
    • Key Player
  • B. Market Analytics
    • Table 60: German Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 61: German Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 62: Italian Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 63: Italian Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • Cholesterol Testing Assumes Importance Amid Rising Obesity Cases
    • Enhanced Focus on Diabetes Management Drives Demand
    • Table 64: Number of Children with Type 1 Diabetes in Select Countries (2015) (includes corresponding Graph/Chart)
    • Key Player
  • B. Market Analytics
    • Table 65: UK Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 66: UK Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 67: Spanish Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 68: Spanish Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 69: Russian Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 70: Russian Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 71: Rest of Europe Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 72: Rest of Europe Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Asia-Pacific: The Rapidly Growing Market for Cholesterol Testing Services
    • Increasing Incidence of CVD Fuels Demand
    • Growing Diabetic Population: A Business Case
    • Table 73: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 74: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 75: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 76: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 77: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 78: Asia-Pacific Historic Review for Cholesterol Screening and Lab Testing Services by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 79: Asia-Pacific 14-Year Perspective for Cholesterol Screening and Lab Testing Services by Geographic Region - Percentage Breakdown of Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Outlook
    • Ongoing Expansion in the Domestic Healthcare Sector Bodes Well
    • Table 80: Healthcare Spending in China for years 2004, 2009 & 2014 (includes corresponding Graph/Chart)
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 81: Chinese Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 82: Chinese Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Outlook
    • Increasing Healthcare Expenditure Augments Market Prospects
  • B. Market Analytics
    • Table 83: Indian Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 84: Indian Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • A Brief Overview of Diagnostics Sector In Select Regional Markets
      • South Korea
      • Malaysia
      • Philippines
      • Singapore
      • Indonesia
      • Hong Kong
  • B. Market Analytics
    • Table 85: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 86: Rest of Asia-Pacific Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • Growing Population of Diabetics & Aged People Enhances Demand
    • Table 87: Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 88: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 89: Aging Population in Latin America and the Caribbean by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Table 90: Aging Population in Latin America by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 91: Latin American Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 92: Latin American Historic Review for Cholesterol Screening and Lab Testing Services by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 93: Latin American 14-Year Perspective for Cholesterol Screening and Lab Testing Services by Geographic Region - Percentage Breakdown of Revenues for Brazil, and Rest of Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

6a. BRAZIL

  • Market Analysis
    • Table 94: Brazilian Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 95: Brazilian Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 96: Rest of Latin America Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 97: Rest of Latin America Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Expanding Diabetic & Older Population Drive Demand for Cholesterol Screening
    • Table 98: African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 99: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 100: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 101: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 102: Aging Population in the Middle East by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Table 103: Aging Population in Africa by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 104: Rest of World Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 105: Rest of World Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top